inter-alpha-trypsin inhibitor heavy chain 4 ; Homo sapiens






1215 Article(s)
Download
PMID
Title
Journal
Pub. Date
#Total Relationship(s)
1 1281869 Carbohydrate determinant NeuAc-Gal beta (1-4) of N-linked glycans modulates the antigenic activity of human immunodeficiency virus type 1 glycoprotein gp120. J Gen Virol 1992 Dec 2
2 1282012 Antibody-dependent cellular cytotoxicity (ADCC) is directed against immunodominant epitopes of the envelope proteins of human immunodeficiency virus 1 (HIV-1). Viral Immunol 1992 Winter 1
3 1282933 The gp120 glycoprotein of HIV-1 binds to sulfatide and to the myelin associated glycoprotein. J Neurosci Res 1992 Dec 5
4 1312106 Galactose receptors and presentation of HIV envelope glycoprotein to specific human T cells. J Immunol 1992 Apr 1 3
5 1316672 CPF-DD is an inhibitor of infection by human immunodeficiency virus and other enveloped viruses in vitro. Virology 1992 Jun 1
6 1321014 The defect seen in the phosphatidylinositol hydrolysis pathway in HIV-infected lymphocytes and lymphoblastoid cells is due to inhibition of the inositol 1,4,5-trisphosphate 1,3,4,5-tetrakisphosphate 5-phosphomonoesterase. Clin Exp Immunol 1992 Jul 2
7 1360148 Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp160. Nature 1992 Nov 26 2
8 1369693 Biologic activities of HIV-1 envelope glycoprotein: the effects of crosslinking. Biomed Pharmacother 1990 1
9 1370558 Identification and characterization of a neutralization site within the second variable region of human immunodeficiency virus type 1 gp120. J Virol 1992 Feb 1
10 1370604 Inhibitory effect of HIV-1 envelope glycoproteins gp120 and gp160 on the in vitro growth of enriched (CD34+) hematopoietic progenitor cells. Arch Virol 1992 3
11 1372142 Immunological analysis of human immunodeficiency virus type 1 envelope glycoprotein proteolytic cleavage. Virology 1992 Apr 1
12 1381907 An O-linked carbohydrate neutralization epitope of HIV-1 gp 120 is expressed by HIV-1 env gene recombinant vaccinia virus. Arch Virol 1992 8
13 1384428 Sulfonic acid polymers as a new class of human immunodeficiency virus inhibitors. Antiviral Res 1992 Jun 1
14 1386485 Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus. Virology 1992 Aug 2
15 1421098 Requirement for macrophages in neuronal injury induced by HIV envelope protein gp120. Neuroreport 1992 Oct 3
16 1426020 gp120 of HIV-1 induces apoptosis in rat cortical cell cultures: prevention by memantine. Eur J Pharmacol 1992 Jul 1 4
17 1431129 CD4 changes conformation upon ligand binding. J Immunol 1992 Dec 1 2
18 1433500 Sulfation of the human immunodeficiency virus envelope glycoprotein. J Virol 1992 Dec 1
19 1457206 Sulfated polyester interactions with the CD4 molecule and with the third variable loop domain (v3) of gp120 are chemically distinct. AIDS Res Hum Retroviruses 1992 Sep 7
20 1466855 Inhibition of gp120 binding to galactosyl ceramide and sulfatide by potential anti-HIV compounds. AIDS 1992 Oct 2
21 1493050 Stable expression of the human immunodeficiency virus type 1 envelope glycoprotein in transfected L cells. AIDS Res Hum Retroviruses 1992 Dec 2
22 1518869 Sequence and expression of a membrane-associated C-type lectin that exhibits CD4-independent binding of human immunodeficiency virus envelope glycoprotein gp120. Proc Natl Acad Sci U S A 1992 Sep 1 7
23 1533631 An efficient phage plaque screen for the random mutational analysis of the interaction of HIV-1 gp120 with human CD4. J Biol Chem 1992 May 5 1
24 1535992 The direct binding of an HIV fragment with granulocytes from healthy subjects and infected patients. Scand J Immunol 1992 Mar 2
25 1549584 Nonrandom distribution of gp120 N-linked glycosylation sites important for infectivity of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A 1992 Mar 15 5
26 1551875 The V3 region of the envelope glycoprotein of human immunodeficiency virus type 1 binds sulfated polysaccharides and CD4-derived synthetic peptides. J Biol Chem 1992 Apr 5 5
27 1575731 Chemical glycosylation of peptide T at natural and artificial glycosylation sites stabilizes or rearranges the dominant reverse turn structure. Biochem Biophys Res Commun 1992 Apr 30 6
28 1616648 Restriction of serum antibody reactivity to the V3 neutralizing domain of HIV gp120 with progression to AIDS. AIDS 1992 May 3
29 1620355 Memantine prevents HIV coat protein-induced neuronal injury in vitro. Neurology 1992 Jul 4
30 1637373 Variant-specific monoclonal and group-specific polyclonal human immunodeficiency virus type 1 neutralizing antibodies raised with synthetic peptides from the gp120 third variable domain. J Virol 1992 Mar 1
31 1656845 Calcium channel antagonists and human immunodeficiency virus coat protein-mediated neuronal injury. Ann Neurol 1991 Jul 4
32 1669708 HIV-related neurotoxicity. Brain Pathol 1991 Apr 6
33 1675677 Selective inhibitory activity of polyhydroxycarboxylates derived from phenolic compounds against human immunodeficiency virus replication. J Acquir Immune Defic Syndr (1988) 1991 1
34 1676283 Lymphocytes from HIV-infected individuals show aberrant inositol polyphosphate metabolism which reverses after zidovudine therapy. AIDS 1991 Apr 2
35 1676893 Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity. Neuron 1991 Jul 2
36 1682045 N-Acetyl-beta-D-glucosaminyl-binding properties of the envelope glycoprotein of human immunodeficiency virus type 1. Carbohydr Res 1991 Jun 25 2
37 1690264 Intracellular proteins of feline immunodeficiency virus and their antigenic relationship with equine infectious anaemia virus proteins. J Gen Virol 1990 Mar 1
38 1691563 Dextran sulfate and other polyanionic anti-HIV compounds specifically interact with the viral gp120 glycoprotein expressed by T-cells persistently infected with HIV-1. Virology 1990 Apr 2
39 1696539 Flow cytometric method to monitor the destruction of CD4+ cells following their fusion with HIV-infected cells. Cytometry 1990 2
40 1697332 Association of antibodies blocking HIV-1 gp 160-sCD4 attachment with virus neutralizing activity in human sera. J Med Virol 1990 Jul 2
41 1698804 HIV-1 envelope protein gp120 expression by secretion in E. coli: assessment of CD4 binding and use in epitope mapping. J Virol Methods 1990 Jul 1
42 1702301 HIV-1 neutralizing monoclonal antibodies induced by a synthetic peptide. AIDS Res Hum Retroviruses 1990 Sep 1
43 1711033 CD4+ lipid bilayers. A model for human immunodeficiency virus type 1 coat protein binding. J Biol Chem 1991 Jun 25 1
44 1711118 Phosphorothioate oligodeoxycytidine interferes with binding of HIV-1 gp120 to CD4. J Acquir Immune Defic Syndr (1988) 1991 2
45 1716631 Stimulation of protein tyrosine phosphorylation, phosphoinositide turnover, and multiple previously unidentified serine/threonine-specific protein kinases by the Pan-B-cell receptor CD40/Bp50 at discrete developmental stages of human B-cell ontogeny. J Biol Chem 1991 Sep 15 3
46 1717587 N-glycosylation of HIV-gp120 may constrain recognition by T lymphocytes. J Immunol 1991 Nov 1 2
47 1718343 Effect of Evans blue and trypan blue on syncytia formation and infectivity of human immunodeficiency virus type I and type II in vitro. AIDS Res Hum Retroviruses 1991 Jun 1
48 1725246 Effect of anti-carbohydrate antibodies on HIV infection in a monocytic cell line (U937). Antiviral Res 1991 Oct 1
49 1727607 Functional roles of the V3 hypervariable region of HIV-1 gp160 in the processing of gp160 and in the formation of syncytia in CD4+ cells. Virology 1992 Jan 1
50 1731112 Human immunodeficiency virus type 1 envelope gene structure and diversity in vivo and after cocultivation in vitro. J Virol 1992 Feb 1